Bowhead Specialty price target raised to $39 from $36 at Morgan Stanley

Morgan Stanley analyst Bob Jian Huang raised the firm’s price target on Bowhead Specialty (BOW) to $39 from $36 and keeps an Equal Weight rating on the shares. The firm is updating its price targets on stocks under its coverage in the P&C Insurance sector, the analyst tells investors. Results were somewhat mixed depending on the segments, but the firm sees further growth and margin expansion in personal lines, which should be durable in 2025. Heading into 2025, the firm expects broader P&C trend to remain steady, with personal lines and brokers leading on the earnings growth front.